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Background: Electronic rating scales represent an important resource for standardized data collection. However,
the ability to exploit reasoning on rating scale data is still limited. The objective of this work is to facilitate the
integration of the semantics required to automatically interpret collections of standardized clinical data. We developed
an electronic prototype for the Scale of the Assessment and Rating of Ataxia (SARA), broadly used in neurology. In
order to address the modeling challenges of the SARA, we propose to combine the best performances from OpenEHR
clinical archetypes, guidelines and ontologies.
Methods: A scaled-down version of the Human Phenotype Ontology (HPO) was built, extracting the terms that
describe the SARA tests from free-text sources. This version of the HPO was then used as backbone to normalize
the content of the SARA through clinical archetypes. The knowledge required to exploit reasoning on the SARA
data was modeled as separate information-processing units interconnected via the defined archetypes. Each unit
used the most appropriate technology to formally represent the required knowledge.
Results: Based on this approach, we implemented a prototype named SARA Management System, to be used for
both the assessment of cerebellar syndrome and the production of a clinical synopsis. For validation purposes,
we used recorded SARA data from 28 anonymous subjects affected by Spinocerebellar Ataxia Type 36 (SCA36).
When comparing the performance of our prototype with that of two independent experts, weighted kappa scores
ranged from 0.62 to 0.86.
Conclusions: The combination of archetypes, phenotype ontologies and electronic information-processing rules can
be used to automate the extraction of relevant clinical knowledge from plain scores of rating scales. Our results reveal
a substantial degree of agreement between the results achieved by an ontology-aware system and the human experts.
Keywords: Rating scales, GDL, Human phenotype ontology, Clinical archetypes, SARABackground
In the clinical domain, phenotypic abnormalities are
defined as alterations in normal morphology (structural
abnormalities such as cerebellar atrophy), physiology
(functional abnormalities such as incoordination of
movement), or behavior (such as difficulty in social in-
teractions) [1]. Acquiring a better understanding of the* Correspondence: maria.taboada@usc.es
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eases is crucial to improve the interpretation of the genetic
tests, and the translation of genomic information into
clinical practice [2]. Unlike genomic technology, collecting
and analyzing phenotype data is not usually conducted
following a standardized process. In clinical research, the
process of collecting data ranges from determining the set
of data to be gathered to decide the most appropriate
computational representation. In general, this is a difficult,
laborious and time-consuming task [3]. Phenotype anno-
tation has a huge potential to automatically extract datale is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
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trolled trials. Recently, substantial progress has been
achieved in encoding phenotypes using the Human
Phenotype Ontology (HPO) [4]. This ontology supplies a
standardized core of human phenotypic abnormalities and
the relationships between them. It is accessible online [5]
and contains over 12,000 classes and 16,000 hierarchical
relationships.
Electronic rating scales represent an important resource
for standardized data collection, often providing primary
and secondary outcome measures. While rating scales are
used in all medical disciplines, they are especially relevant
in specialties with a richness of complex phenotypic vari-
ables, such as neurology [6]. Clinical scales can measure
the so-called latent variables, i.e., variables that can only
be assessed indirectly through their manifestations. Exam-
ples of latent variables (or clinical dimensions) in neuro-
logical diseases include the quality and intensity of a
tremor, the degree of gait imbalance or cognitive perform-
ance. These latent variables are assessed through a set of
clinical questions (named statements or items) [7]. Each
statement may have multiple ordered response options,
for which an ordinal number (score) is assigned. The total
score for the global clinical dimension is usually obtained
adding up all individual scores for each statement. Well-
known examples are the Mini-Mental State Examination
[8], a 30-point survey used to measure cognitive impair-
ment, or the Glasgow Coma Scale [9] to assess coma and
impairment of consciousness. These instruments improve
data quality by reducing subjectivity in phenotype descrip-
tions, and by simplifying the design of data collection pro-
tocols in research studies. Usually, rating scales grade
several clinical dimensions through different items. For
instance, in addition to the movement disorder (i.e., dis-
ease state), the Unified Parkinson’s Disease Rating Scale
assesses other clinical sub-dimensions (such as mental
state, complications of treatment and activities of
daily life) via 42 questions that provide a total score
[10]. Reducing all content of a rating scale to a
unique number (total score) may lead to loss of use-
ful clinical information about the dimensions impli-
citly collected by the scale. Hence, inferring the
patient’s phenotype components from the sub-scores
would facilitate medical evaluation, report writing,
and clinical decision-making. In this work, we chose
to address the Scale for the Assessment and Rating of
Ataxia (SARA) [11], a well-validated instrument to
evaluate the presence and severity of cerebellar ataxia
[12]. This scale is broadly used and has been applied
by our group in a research on the spinocerebellar
ataxia type 36 (SCA 36). A use case for the SARA
scale is illustrated below.
Formal description of rating scales using standard clin-
ical information models promotes computational datastandardization, which is crucial for comparing results
across studies [13], to integrate information among dif-
ferent applications and medical records, and to imple-
ment decision support systems. International consortia
have developed standardized data models for clinical
research and electronic health records, such as ISO
13606 [14], HL7 CDA [15], openEHR [16], NINDS CDE
[3] and Intermountain Healthcare [17]. These efforts
have focused on providing computable and formal speci-
fications of clinical content, known as clinical models or
archetypes. Such models also provide mechanisms to
link the clinical statements to classes of some standard
terminology or ontology. Both clinical archetypes and
ontologies seek to structure patient information, accord-
ing to the needs of clinical research and practice; how-
ever their perspectives are different. Archetypes model
the information to mirror patient records. For example,
the items paraparesis and facial palsy were recorded to-
gether into the archetype Stroke Scale Neurological
Assessment, which is available on the Clinical Knowledge
Manager (CKM) provided by the OpenEHR Foundation.
Ontologies, on the other hand, aim to represent the
meaning and relationships between clinical terms. For
example, both paraparesis and facial palsy are repre-
sented as abnormalities of the nervous system in the
HPO. However, the former is represented as an abnor-
mality of the physiology, whereas the second one as an
abnormality of the morphology. This ontological distinc-
tion cannot be reflected into the clinical archetype and
however it is valuable to interpret the patient status.
Thus, integrating ontologies with clinical archetypes
would not only provide a static knowledge store, but also
a dynamic resource to automatically infer patient pheno-
type and standardize data collection.
Modeling rating scales by clinical archetypes
Braun et al. [18] modeled a rating scale for the assess-
ment of multiple sclerosis patients, following a standard
archetype development approach. On this basis, ontol-
ogy mapping was delayed until the final stages of mod-
eling. At this late stage, the effort required to map
archetype terms to ontology entities is substantial [19],
due in part to the large size of the ontologies [20]. Fur-
thermore, designing clinical archetypes separately from
ontologies may lead to major discrepancies in the
meaning of the clinical statements. As a result, ontol-
ogy mappings – key to achieve semantic interoperabil-
ity among different data sources - are not common in
the openly accessible archetypes.
Exploiting reasoning on clinical archetypes
Exploiting reasoning on clinical archetypes is another
challenge. The Guideline Definition Language (GDL) is
a formalism to express decision support logic by a rule-
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reliable for guideline compliance in acute stroke and
chronic kidney disease [21, 22]. However, GDL does
not provide much support for ontologies and related
reasoning. An alternative is to transform clinical
archetypes/models into OWL-DL (Ontology Web
Language – Description Language) [23–26]. Following
this approach, ontology reasoners, such as Pellet, Her-
mit or Fact++, can be used to check the OWL-based
archetype consistency [24], and make automated rea-
soning over the OWL dataset. This structure provides
support for interoperability of rule-based mechanisms
[24, 27, 28]. However, having two independent
versions of the same standard model - one in the lan-
guage of the model itself (ADL-Archetype Definition
Language) and the other in OWL - makes mainten-
ance more difficult. Furthermore, procedural know-
ledge as the sum of the scores in a scale (or any
complex calculation function) cannot be simply repre-
sented in terms of OWL. An interesting alternative
proposed by Mugzach et al. [28] to perform a par-
ticular counting in OWL (named k-of-N counting by
the authors) was to develop a plug-in meeting the
specific requirements. However, different calculation
functions would then require implementing specific
plug-ins. Other researchers defined knowledge-
intensive mappings from the data sources to open-
EHR archetypes [29, 30]. They distinguished between
data-level and knowledge-level processing tasks. The
former included calculation functions specified in the
mappings and directly run on archetype data. The lat-
ter covered classification tasks defined using OWL
classes with sufficient conditions. An integrated
Personal Health Record is an alternative option to
simplify data integration and clinical decision-making
[31].
Scale for the assessment and rating of ataxia
The SARA assesses severity of cerebellar dysfunction
through the evaluation of eight items reflecting motor
performance (gait, stance, sitting, speech disturbance,Table 1 An example scenario
Patient 1 2 3 4 5-R 5-L 6-R
1 6 6 3 1 0 0 1
Mean R-L 0 1
2 2 2 1 3 3 4 3
Mean R-L 3.5 3.5
3 2 2 1 6 1 4 1
Mean R-L 2.5 2.5
Table shows three hypothetical patients with the same value for the total SARA score. It
5-Finger-chase test, 6-Nose-finger test, 7-Fast alternating hand movements and 8-Heel-s
and L, left. Mean R-L is the mean value of both sidesfinger-chase test, nose-finger test, fast alternating hand
movements and heel-shin test) [32]. For the last four
items, upper and lower extremities are evaluated bilat-
erally, the mean values of both sides are calculated and
added up to the scores of the first four items. The total
score ranges from 0 (no ataxia) to 40 (most severe
ataxia). The SARA is used in clinical studies for a more
accurate evaluation of the patient’s motor performance,
both globally and at the individual items. It is also useful
for quantitative comparison of patients, ataxia types, dis-
ease stages and response to treatment, among other
applications. One of the challenges of the SARA is the
need to derive a qualitative description and patient clas-
sification with diagnostic implications from numerical
scores. An automated system to solve this translation
would greatly facilitate the use of the SARA – and, by
extension, other scoring systems- by clinicians on both
research and clinical routine settings.
A use case description
Let’s consider patients 1, 2 and 3, with the same total
SARA score of 20 (Table 1). Just based on the total
score, the three patients would be considered to be in
similar clinical stage. However, their functional situation
is notably different. While patient 1 scores very high for
midline ataxia (which is concluded from the high values
of the three first items) and can barely walk or sit
unaided, patients 2 and 3 have compromised speech
(item number 4) and limb coordination (from the
values of the last four items). In turn, patients 2 and
3 – with similar sitting, standing and walking per-
formance – have different degree of speech impair-
ment (mild in patient 2, while verbal communication
is impossible for patient 3). The total – and even just
partial scores for limbs – also do not help differenti-
ate the actual phenotype of patients 2 and 3, who
have very different performance with their limbs (appen-
dicular ataxia derived from the last four items). While
patient 2 has significantly impaired motor coordination on
both sides, patient 3 has a more asymmetrical cerebellar
syndrome, with severe impairment on his left side, but6-L 7-R 7-L 8-R 8-L Total Score
1 1 1 2 2
1 2 20
4 3 3 2 2
3 2 20
4 1 4 0 3
2.5 1.5 20
ems are represented by numbers: 1-Gait, 2-Stance, 3-Sitting, 4-Speech disturbance,
hin test. Upper and lower extremities are evaluated bilaterally. R represents Right
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of enormous relevance to his functional ability if the
patient is right-handed.
Specific contribution
The main goal of our work was to develop an electronic
rating scale in the clinical domain of the neurology
representing both the content and the interpretation of
the SARA, using the Electronic Health Record (EHR)
standards and taking advantage of semantic web tech-
nologies. In order to facilitate ontology mapping and
prevent large semantic discrepancies between clinical
archetypes and ontologies, we propose a novel method
based on the assumption that archetype design should
be supported by ontologies in those clinical situations
where the archetype contents are logically organized.
On the other hand, the interpretation of the SARA
required different types of information: data to be re-
corded (i.e., the content of the rating scale), knowledge
about the meaning of terms in the scale (i.e., termino-
logical knowledge), procedural knowledge to under-
stand the meaning of scores (that can be easily
expressed by guidelines), and ontological knowledge to
deduce patient phenotypes. We chose to use a combin-
ation of GDL, openEHR clinical archetypes andFig. 1 The modeling approach. It includes: 1) Extraction of a scaled-down
items and scores; 3) Development of two archetypes (Observation and Eva
express the clinical interpretation of the SARAontologies to address the challenges of modeling the
rating scale. The research questions addressed in this
work are: (1) is the combination of GDL, openEHR
clinical archetypes and ontologies suitable for the
description of all knowledge covered by the SARA?,
and (2) is it possible to achieve a reasonable integration
of these technologies to efficiently model the rating
scale?
Methods
Our modeling approach is based on four main steps (Fig. 1):
(1) building of a scaled-down of the HPO, through extrac-
tion of the ontology modules relevant to the SARA, 2)
annotation of the free-text descriptions of the rating scale
with the ontology modules, 3) development of two clinical
archetypes, Observation (for normalizing the scale content)
and Evaluation (for recording the clinical interpretations),
and 4) Definition of the information-processing units to
express the clinical interpretation support system. Each
step involves several activities, described below and sum-
marized in Fig. 2.
The modeling of SARA involved a data level - repre-
sentation of the SARA items- and a knowledge level-
referred to the strategy to compute the total score and
interpretation of phenotype. Archetypes were used toversion of the HPO; 2) Annotation of the free-text descriptions of SARA
luation); 4) Definition of the information-processing units in order to
Fig. 2 Summary of the main proposed activities for the modeling of electronic rating scales. They cover: extracting ontology modules, annotating
the scale, building archetypes, and expressing interpretation
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model the knowledge level. This representation had
restrictions, since openEHR models support GDL, but
do not give much support for OWL and related reason-
ing. To bring the gap between the clinical archetypes
and the ontology, mappings were defined. These map-
pings facilitated the translation of the archetype
instances to the OWL dataset.
Extracting the HPO ontology modules relevant to the
SARA
We reviewed and collected free-text sources describing
the SARA, its component tests and application. For ex-
ample, the following text describes the functional subdi-
visions of the cerebellum in order to explain the
rationale of a coordination exam: “The cerebellum has 3
functional subdivisions, …. The first is the vestibulocere-
bellum. … Dysfunction of this system results in nystag-
mus, truncal instability (titubation), and truncal ataxia
... The following tests of the neuro exam can be divided
according to which system of the cerebellum is being ex-
amined….”. We then annotated the sources to HPO
terms, using the OBO Annotator [33], a phenotype con-
cept recognition system. In total, 12 HPO classes were
selected from the annotations (Additional file 1), which
provided the set of seed terms required to extracting a
self-contained portion of the HPO. Such scaled-down
version of the HPO covered all the classes relevant to
the SARA (in total, 45 subclasses of phenotypic abnor-
malities). In general, self-contained portions of an ontol-
ogy are referred as ontology modules/segments [34], or
slims in the context of the Gene Ontology. While these
modules are subgroups of a base ontology, in our case
the HPO, they are also equally valid on their own [35],
but simpler and more manageable than the complete
ontology.
Annotating the rating scale SARA
We used the scaled-down version of the HPO to anno-
tate all items and scores of the SARA. First, we partially
matched the SARA items to the ontology classes. Partial
match happened when the item name was embeddedinside a class name. Next, a neurologist (MJS) revised
the candidate mappings, selected the most appropriate
classes and proposed a minimal extension and
reorganization of the scaled-down version of the HPO.
Additional classes and relationships, as well as the map-
pings between items and classes are summarized in
Fig. 3.
In order to annotate the item scores, we reused the
HPO classes describing different levels of severity: bor-
derline, mild, moderate, severe and profound. We added
new subclasses based on the severity levels of their su-
perclasses. For example, moderate_dysarthria was
defined as a subclass of dysarthria with a moderate
severity. Two severity scores were identified as equiva-
lent to existing HPO phenotypes: the score 8 for the
item gait, which was mapped to the class abasia; the
score 6 for the item speech disturbance, which was
mapped to anarthria. We also added a new class (named
astasia) to map the score 6 to the item stance, and two
main superclasses: i) truncal ataxia, which subsumed
the classes gait_ataxia and ataxic_postural_instability
(which subsumed standing_instability and sitting_inst-
ability); and ii) appendicular ataxia, which subsumed
limb dysmetria, intention tremor and dysdiadochokinesis.
Finally, the SARA-specific, scaled-down version of the
HPO was translated to Protégé, its properties were
manually modeled and the HermiT reasoner was used to
check for consistency. In total, our scaled-down version
of the HPO contains 109 subclasses of phenotypic
abnormality (Additional file 2).Developing the archetypes for the SARA
For archetype design, we chose two types of clinical ar-
chetypes: Observation and Evaluation. The first was used
to normalize the scale content (i.e., clinical dimensions,
items and scores), whereas the second was used to rec-
ord the clinical interpretations and phenotypic abnor-
malities derived from the achieved numerical scores.
Both clinical archetypes were developed using the arche-
type editor provided by OpenEHR (Additional files 3
and 4).
Fig. 3 Excerpt from the set of mappings between the SARA and the ontology. Squares represent the SARA items. Gray and golden
ellipses, respectively, are the original HPO classes and classes added to the ontology modules. Blue arrows are mappings between SARA
items and HPO classes. Black and golden arrows, respectively, represent the original and the additional is_a relationships. Note that
subsumptions in Electronic health record (Open Biological Ontologies) are represented using the is_a relationship, whereas in OWL using
the subclassOf constructor
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metadata (e.g. purpose, keywords, definition, author,
etc.), we structured the content of the SARA according
to this archetype, i.e., by means of a tree structure with
elements for the three clinical dimensions (the set of
items, the total score and the date of the observations),
and values for the individual scores. Then, we defined
the elements with proper data types, descriptions,comments, details, occurrences, constraints and possible
values. We mapped each element to the corresponding
ontology class of the scaled-down version of the HPO,
using the achieved annotations (see Annotating the
rating scale SARA). Finally, we structured and organized
the items in accordance with the ontology, by inserting
three CLUSTER nodes in a hierarchical structure: i) gait
and balance, which was linked to truncal ataxia; ii)
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iii) upper and lower limb coordination, which was associ-
ated with appendicular ataxia. This new structure did
not alter the SARA, as it continued to be based on the
same 8-items, but only arranged these items in a specific
way (Fig. 4a). The new nodes can be viewed as clinical
dimensions, but without any assigned score. Fig. 4b
shows that the observation archetype meets the rating
scale structure.
The evaluation archetype (Fig. 5) recorded the clinical
interpretations derived from the numerical scores (collected
following the Observation archetype). We modeled this
archetype following the same structure as the observation
archetype - i.e., by means of a tree with three main clusters,
one for each main clinical dimension: gait & balance,
speech disturbance, and upper & lower limb coordination.
Each cluster consisted of the interpretations directly or in-
directly derived from the corresponding elements in the
observation archetype. Additionally, since every element in-
volved different levels of severity, so the “choice” data type
was selected with Text/ Internal codes as constraints.
Finally, we mapped the elements to ontology classes.
Modeling the knowledge required to interpret the SARA
data collection
The SARA scale supplies standardized calculation func-
tions, but it does not provide interpretation knowledge.
Thus, we analyzed the information-processing unitsa
Fig. 4 The structure of the content of the SARA. a The new organization o
balance, speech disturbance, and upper and lower limb coordination; b Threquired to automatically interpret the data obtained
through the application of SARA (Table 2). With the
support of the ontology and acquiring the experience of
the neurologist, we were able to express the interpret-
ation of the SARA, although this is not standardized.
The calculation functions expressed the mathematical
operations to compute both the arithmetic means of the
item scores and the total score. The input and output of
these functions were elements defined in the observation
archetype. In total, five GDL rules were modeled to
cover these functions (Fig. 6). Cut-off levels are usually
used to grade the severity of the scale items (i.e., ele-
ments in the observation archetype). Translating these
cut-off levels to GDL required 61 rules. For example, if
the score of the item sitting is 4, then the sitting instabil-
ity is registered as severe (Fig. 7). Assessment of the
cerebellar syndrome was based on the total score. The
neurologist proposed several heuristic rules, which were
modeled using GDL. Fig. 8 shows the rule inferring the
absence of cerebellar syndrome. This knowledge was
aligned with the results in [11], where the mean SARA
score for controls was 0.4 ± 11.
A clinical synopsis was built to outline the phenotypic
features accompanying the cerebellar syndrome. One
example of such features is midline ataxia (truncal
ataxia) (Fig. 5), derived from the scores of the first three
SARA items and leveraging the scaled-down version of
the HPO. It required using elements and values from theb
f the SARA, with three main patient’s phenotype components: gait &
e clinical archetype developed for the SARA
Fig. 5 Structure of the evaluation archetype. It covers all the
interpretations that can be derived from the SARA
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standing instability) to infer other elements and values
from the same archetype using the OWL ontology. Dur-
ing this modeling phase, we could only simulate ontol-
ogy reasoning using the Protégé tool. From the valuesTable 2 Information-processing units. Each unit is defined by mean
representation language
Information-processing units Knowledge format I
Calculation functions Mathematical expressions O
Assessment of the degree
of impairment
Cut-off level based severity rules O
Assessment of cerebellar syndrome Heuristic rules O
Clinical synopsis Scaled-down version of the HPO Einferred by the GDL for elements of the evaluation arche-
type, and taking into account the mappings of this arche-
type, we manually entered the individuals of the linked
OWL classes and run the reasoner. Additional file 5
provides the rules modeled in the GDL.
Results
System implemented in JAVA and MySQL
To demonstrate the functionality of our approach, we
developed a framework entitled “SMS” (SARA Man-
agement System), to be used for both the assessment
of cerebellar syndrome and the production of a clin-
ical synopsis. We used JAVA as programming
language, NetBeans as integrated development envir-
onment, JAVA Swing as user interface toolkit, and
MySQL as database management system. The SMS
architecture was structured in three layers: “Persist-
ence”, “Operation” and “Interface”. The persistence
layer used MySQL to store the clinical archetypes,
the patient input data, the data inferred by the sys-
tem, and additional information. Fig. 9 shows the re-
lational model of the database with three types of
tables. The first type included the class, subclass,
scale, element and value tables. All of them modeled
the attributes of the clinical archetypes (elements,
values and mappings to ontology classes). To a
greater extent, they were built based on the structure
of the modeled archetypes. In order to populate the
database with data from the archetypes, the ADL
parser provided by the OpenEHR Foundation was
used to generate a dependency tree of terms and then
create an XML file, which was aimed at producing
archetype instances when needed. The second type of
tables stored the patient data, and the last type (test
and test_value tables) recorded the set of SARA tests.
The operation layer included all information-
processing units (Table 2). The used version of GDL
did not provide a Java API or any mechanism for ma-
nipulating the rules defined using the editor. Hence,
the only solution was to rewrite the rules in a rule
engine (such as Drools or Clips) or to implements of the used knowledge format, the inputs, outputs and the
nput Output Representation
language
bservation archetype items Observation archetype
items
GDL
bservation archetype item Evaluation archetype
items
GDL
bservation archetype items Evaluation archetype
items
GDL
valuation archetype items Evaluation archetype
items
OWL
Fig. 6 Example of a calculation function. It is expressed by a GDL rule. The function calculates the mean of an “element” defined in the
observation archetype (specifically, the element finger chase). The output of the rule refers to another element of the same observation archetype
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However, deriving phenotype information was reason-
ably implemented using the OWL API [36] and the
mappings linking the archetype elements and values
to OWL classes. The mappings were useful to auto-
matically create OWL individuals from the archetype
instances stored into the database.
The interface layer consisted of several input and out-
put forms. The main form of the tool provided three
menus. The first one allowed users to modify the struc-
ture of the ontology (Fig. 10), by adding, updating or de-
leting classes. Additionally, it provided an option to
automatically generate a hierarchical graph that dis-
played all the available classes and their is_a relation-
ships. The second menu automatically generated entry
forms based on the defined archetypes (Fig. 11). These
forms were used to collect patient data from the user
and run the tool. The third menu displayed the out-
comes (Fig. 12):
 A table with all phenotypic abnormalities inferred
from the collected patient data.
 A textual report summarizing the patient status. The
report included the assessment of cerebellar
syndrome and a brief synopsis of the phenotypic
abnormalities accompanying the syndrome.
 An evaluation graph visualizing all the patient
phenotypic abnormalities (Fig. 13).Fig. 7 GDL rule to assess the degree of sitting instability. The rule links theTo facilitate semantic interoperable data exchange, the
approach was designed to deliver the XML data collected
by the SARA and also inferred by the application. Add-
itionally, the system provided the facility to send the
SARA results and the patient report by e-mail. The doctor
could attach it to the patient medical record.Validation of the system
For validation purposes, we used anonymized data re-
cords from 28 subjects with Spinocerebellar Ataxia
Type 36 (SCA36), who had been examined with the
SARA scale [37]. The institutional research ethics
committee approved the recruitment and study proto-
col, and all participants gave their written informed
consent. Only the scores for each SARA item were
used for this evaluation, by two independent neurolo-
gists. The validation was carried out in three steps:
1) Automatic total score calculation and
interpretation: We filled out the score data for
each patient to get the interpretation. The system
automatically inferred 1) severity for each item in
the scale, 2) assessment of cerebellar syndrome,
and 3) clinical synopsis.
2) Interpretation by two independent experts in
movement disorders. These neurologists analyzed
the same data set blindly and independently. Theyscore 4 for the “sitting” item to the “severe sitting instability” class
Fig. 8 GDL rule for absence of cerebellar syndrome
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truncal and appendicular ataxia from the
individual scores, according to their expertise.
3) Comparison of the results obtained by the system
and human experts, with a results-oriented valid-
ation perspective [38]. This perspective is based on
comparing the performance of the developed tool
with an expected performance provided by human
experts. Among the methods to assess inter-rater
agreement [39–42], we chose Weighted Kappa, as it
is more compatible with ordinal scales, such as the
SARA. Weighted Kappa is an inter-rater agreement
measure for categorical items. It takes into account
the possibility of agreements occurring by chance
and it counts the disagreements differently - by
weighting them. Using SPSS package, we ran
Weighted Kappa test 12 times to measure the
strength of agreement between the system and each
neurologist, as well as between both neurologists.
Table 3 displays the Weighted Kappa values between
automated and manual ratings. These values ranged be-
tween 0.62 and 0.86. In order to test whether the per-
formance of the system reached limits considered as
acceptable, we needed to define appropriate limits. Lan-
dis and Koch [43] proposed the cut-off levels shown in
Table 4 to interpret kappa statistic. Table 5 shows the
interpretation of the results of Table 3, following the
Landis & Koch criteria.
Discussion
In this paper, a mixed method to support the develop-
ment of the SARA has been presented. The method
combined OpenEHR archetypes, guidelines, ontologies
and reasoning. The innovation of our method rests on
how these approaches were combined to get the full
benefit of them. We distinguished between the modeling
phase and the implementation phase. During the former,
we addressed the calculation and assessment tasks by
defining and executing GDL rules, and the clinicalsynopsis task by defining OWL classes and executing a
reasoner. However, due to the lack of integration
between these frameworks, we first ran the GDL frame-
work, and then we manually entered the results in Pro-
tégé in order to infer the phenotypic abnormalities.
During the implementation phase, we addressed the
calculation and assessment tasks by rewriting the rules
directly in Java, and the clinical synopsis task by inte-
grating the OWL API into the system and using the
mappings to create OWL individuals. We designed the
approach as an archetype-based stand-alone application,
providing a meaningful way for collecting and interpret-
ing healthcare data. The application released the local
EHR system of integrating the SARA, providing a stand-
ard way of delivering the collected and inferred data.
Thus, the main role of this electronic rating scale was to
collect the normalized data, execute the decision support
logic and deliver both data and interpretations to the
EHR system.
Turning to the research questions in this paper, a few
conclusions can be drawn. With respect to question (1)
- Is the combination of GDL, openEHR clinical arche-
types and ontologies suitable for the description of all
knowledge covered by the SARA?) -, we can conclude
that a combination of OpenEHR, GDL and OWL offers
a suitable framework for the purpose of describing the
data and knowledge levels of the SARA. OpenEHR pro-
vides a formal specification at the data level, whereas
GDL and ontologies offer formal specifications of differ-
ent types of knowledge for data interpretation purpose.
However, it should be emphasized that in our particular
case, the knowledge level could be broken into separate
information-processing units interconnected in a simple
way through the two defined archetypes. However, the
interpretation of a rating scale may require more com-
plex control mechanisms, demanding more interoper-
ability between GDL and OWL. Furthermore, the
current version of GDL uses archetype data as input and
output variables for all the rules, but it provides no facil-
ity to define auxiliary variables. This type of variables is
sometimes necessary to model procedural knowledge,
such as the counting of the scores in rating scales. At
Fig. 9 Database relational model. The table ‘patient’ recorded the patient identifier, the tables ‘test’ and ‘test_values’ stored the information about
the tests covered by the SARA, and the rest of the tables recorded the information modeled in the clinical archetypes
Maarouf et al. BMC Medical Informatics and Decision Making  (2017) 17:159 Page 11 of 17the moment, there are two solutions: 1) adding new
elements to the archetype, or 2) defining an auxiliary
archetype containing all the needed variables. The ad-
vantage of this second option is that leaves intact the
original archetype.
The new major version of ADL includes specifications
for defining explicit rules of invariant assertions, i.e.,expressions that should be satisfied by all instances of an
archetype. These assertions cover some calculation func-
tions over one or several items, and also definitions of
mandatory items in the presence of specific values of
other items. The definition of these rules provides the
same functionality as some of the GDL rules defined in
our system. However, the syntax of these specifications
Fig. 10 Screenshot of ontology update. The form can be used for checking, remove and update classes of the scaled-down version of the HPO
used by the SMS. All the classes can be viewed in both graphical and tabular formats
Maarouf et al. BMC Medical Informatics and Decision Making  (2017) 17:159 Page 12 of 17is not stable and it is still a need of tools that offer sup-
port for the automatic handling of invariants on arche-
type instances. Similarly, the new ADL specification
covers a section for mapping to external terminologies,
which has been improved with richer mappings. Specif-
ically, it is possible to map post-coordinated archetype
codes to ontology pre-coordinated classes. This facility
can be very relevant when ontology mapping is carried
out in the final stages of the modeling process.
With respect to question (2) - Is it possible to achieve
a reasonable integration of these technologies to effi-
ciently model the rating scale? -, we showed that a full
integration of these technologies to model the rating
scale is not possible at the moment. In the modeling
stage, the use of GDL facilitated the development andFig. 11 Observation form where neurologists can enter the values of the Sinterconnection of most processing units, without
resorting to external resources and encouraging know-
ledge sharing. We could verify and validate the SARA by
testing use cases in the GDL editor. We should bear in
mind that this tool automatically generates entry forms
based on the defined archetypes. The forms are used to
collect data from the user, run the engine and display
the outcomes. However, the editor does not supply any
other facility for delivering the outcomes. For example,
the generation of XML instances of the archetypes
would be a remarkable advance to provide the option of
combining the tool with other different inference en-
gines, such as description logic reasoners. Regarding to
ontology reasoning, testing use cases based on arche-
types and OWL requires tools that automate the processARA scale items
Fig. 12 Screenshot of entry forms. It displays an example of phenotypic abnormalities derived from the data of a patient (on the left side) and a
textual report summarizing the status of this patient (on the right side)
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run the reasoner on the OWL dataset, and deliver the
outcomes as instances of the archetypes.
In the implementation stage, the used version of GDL
did not provide any utility to translate the modeled rules
into some execution engine (e.g., drools or clips), as has
been mentioned previously. Thus, this part of the imple-
mentation required substantial effort. In order to
decrease the time devoted to implementation, we parsed
the ADL archetypes and developed a database model
based on the archetype structure. Regarding to ontology
reasoning, the archetype mappings facilitated the trans-
lation of the archetype instances into OWL individuals.Fig. 13 Screenshot of a graphical summary. It displays a graph visualizing
ellipses represent the lower classes in the hierarchy and the yellow ellipsesThe suggested approach not only focuses on the syntac-
tic structure of the SARA, but also on leveraging a scaled-
down version of the HPO from the earliest stages of the
modeling of archetypes. This ontology version was a valu-
able resource to facilitate 1) the syntactic structure of the
rating scale, 2) the terminology mapping, 3) the auto-
mated interpretation of collected data, and 4) the commu-
nication process among the information-processing units.
Regarding the first point, we organized the SARA items
by means of a tree structure (Fig. 5b), using the CLUS-
TERS class provided by OpenEHR. As mentioned above,
this new organization preserved the 8-item performance
of the original scale. It also differentiated the three mainthe set of phenotypic abnormalities inferred by the SMS. The green
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assessed quantitatively. Following the OpenEHR docu-
mentation, the CLUSTERS class is provided to represent
common domain patterns required in many clinical sce-
narios. The clinical dimensions identified into the SARA
can be viewed as common domain patterns that provide a
more accurate assessment of the patient’s phenotype com-
ponents, clarifying the interpretation of the results. How-
ever, the observation archetype that was uploaded to the
CKM, where is publicly accessible, follows the flat struc-
ture of the original rating scale. As the main goal of the
CKM is to provide high-quality information models, the
CKM consortium considered that a flat structure that
complied with the original scale structure was more
convenient. However, we think the approach presented
here remains valid, as usually rating scales grade several
clinical dimensions [7] and the proposed structure using
CLUSTERS classes allows the proper representation of
these dimensions. On the other hand, the evaluation
archetype was not uploaded to the CKM, as only those
archetypes that are based on some documented inter-
national assessment or very generic requirement are
accepted. Following the CKM recommendations, the
SARA evaluation archetype is perfectly suitable for
local use.
Regarding the second point, mappings to standard
vocabularies are uncommon in the clinical archetypes
that are published in openly accessible repositories. In
general, terminologies include a huge number of clinical
terms; so manual mapping turns out to be unfeasible in
practice. The extraction of the scaled-down version ofTable 4 Kappa interpretation rules by Landis and Koch (1977)






0.81-1.00 Almost Perfectthe HPO provided us a means of performing terminology
mapping in the earliest stages of archetype building. Just
as for the clinical archetype, some parts (i.e., classes and
relationships) of the scaled-down version of the HPO were
reorganized to cover the SARA domain required for the
ontology-driven modeling. This approach, known as
ontology reuse, is an important design principle in ontol-
ogies [44, 45] that facilitates the development of specific
applications.
Regarding the third point, the ontology version pro-
vided the knowledge required to infer patient phenotypic
information from the data collection. For example, from
the score 8 of the item gait, the system inferred that the
patient had abasia, and so gait ataxia. However, exploit-
ing reasoning on both ADL and ontologies is not pos-
sible at the moment. In our approach, this reasoning
was needed to interpret the presence of the phenotypic
abnormalities associated to the clinical dimensions of
the scale. As mentioned early, a critical success factor
for exploiting reasoning is the availability of ontology-
based reasoning tools that use data expressed in ADL
format and with capabilities to fire GDL rules. Such an
integrated editor would assist with the effort at the
authoring level. On the other hand, following the
approaches developed in [24, 27, 28], we will transform
the clinical archetypes into OWL-DL and use the ontol-
ogy and rule-based mechanisms provided by Protégé to
draw interpretations on data collection, with the goal of
comparing the results with the ones achieved the
approach developed in this work.
With regard to the interpretation of the results of our
application, Table 5 reflects a very high degree of agree-
ment between the system and the two neurologists, con-
firming that the approach can be a good solution to
develop electronic rating scales. Even so, these excellent
results should also be viewed with much caution, as the
validation was carried out only with 28 patient data, all
of them affected by the same rare disease (SCA36). Add-
itionally, although the two neurologists who carried out
the assessment were independent, they work in the same
hospital and one of them is in the same research group
as MJS, the neurologist involved in the modeling
process. It therefore has to be assumed that there exists
consistency between the three neurologists. Therefore,
in our future work, we will evaluate the application
with a larger number of patient data that are affected
by diverse cerebellar ataxias, and with the help of
neurologists from different hospitals. If the results are
still highly satisfactory, we will develop a simple mo-
bile application for the automatic transmission of the
interpretation to the health information system. In
contrast to the SMS, which was developed as a local
version, the mobile application will be available for
download.
Table 5 Strength of agreement between automated and manual ratings. It follows the interpretation rules proposed by Landis and
Koch
System vs. 1st Neurologist System vs. 2nd Neurologist 1st Neurologist vs. 2nd Neurologist
Strength of agreement Strength of agreement Strength of agreement
Cerebellar syndrome Almost Perfect Almost Perfect Almost Perfect
Midline Ataxia Substantial Almost Perfect Almost Perfect
Appendicular Ataxia (Right) Substantial Substantial Almost Perfect
Appendicular Ataxia (Left) Substantial Substantial Almost Perfect
Maarouf et al. BMC Medical Informatics and Decision Making  (2017) 17:159 Page 15 of 17Finally, although our approach was designed to imple-
ment a prototype for managing the SARA, it is rather
generic and hence applicable to model other electronic
rating scales, possibly in other clinical domains. To take
an example, the approach could be applied to the do-
main of the autism spectrum disorders, which exhibit
complex phenotypes affecting variables that are difficult
to measure. As a consequence, standardized scales are
often used to collect a large amount of phenotypic data.
Recently, a phenotype ontology has been developed to
identify behavioral features of importance [46]. The
availability of this ontology and also the mappings to the
rating scales would facilitate the implementation of pro-
totypes like the one presented here.
Conclusions
Nowadays, the most ataxic disorders still have no suc-
cessful pharmacological therapy, and patients suffer
the unavoidable degenerative disease progression. The
aim of well-validated rating scales is to understand
better the natural history of ataxic disorders and
evaluate properly drug efficacy in clinical trials. In the
present study, we focus on supporting an automatic
interpretation of the SARA data collection. The work
contributes to a better understanding of how clinical
archetypes, guidelines and ontologies can be com-
bined for modeling and implementing the SARA.
There are several contributions in this paper. One
contribution is an ontology-aware approach to model-
ing the two proposed clinical archetypes, which
reduces the effort necessary for creating mappings
and prevents large semantic discrepancies between
the modeled archetypes and the ontology modules.
Another contribution is the clear and explicit separ-
ation between the standard components of the scale
related to the content (i.e., items, clinical dimensions
and scores), which have been modeled using an obser-
vation archetype, and the clinical interpretations of
these components, which have been normalized by an
evaluation archetype for local use. Finally, a key con-
tribution is the clear identification of all different
types of knowledge required to interpret the data
collected by the scale, and their modeling as
information-processing units that communicate withone another via the two defined archetypes, providing
a simple mechanism of combining ontology and rule-
based reasoning.
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